{"companyId":285657,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"XORTX Therapeutics Inc.","headOfficeLocation":"3710 - 33rd Street NW Calgary, AB T2L 2M1 Canada","presidentName":"Allen Davidoff","companySummary":null,"stockCode":"XRTX","currency":"USD","capital":null,"sales":null,"employees":3,"employeesConsolidated":null,"humanCheck":false,"domains":["xortx.com"],"businessContents":["Clinical-stage biopharmaceutical company","Drug development for gout and progressive kidney disease"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://xortx.com/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0}]}